News

December 12, 2018December 12, 2018

Eloctate and Alprolix Show Long-Term Effectiveness for Hemophilia in Extension Studies

News

Treatment of severe hemophilia A with Eloctate and hemophilia B with Alprolix was safe and improved the patients’ annualized bleed rates (ABRs) over four years, according to the results of two extension studies ... Read more

December 10, 2018December 10, 2018

New Analysis Confirms Hemlibra’s Sustained Efficacy in Controlling Bleeding in Some Children With Hemophilia A

News

A new analysis of the Phase 3 HAVEN 2 study’s results shows that Genentech’s Hemlibra (emicizumab-kxwh) prophylaxis (preventive treatment) leads to significant reductions in the number of bleeds among hemophilia A children younger ... Read more

December 7, 2018December 7, 2018

Adynovate Approved in Canada for Hemophilia A Patients Younger Than 12

News

Health Canada recently authorized Shire Pharma Canada‘s treatment Adynovate for hemophilia A patients younger than 12 based on results of a Phase 3 clinical trial. Approved Nov. 21, the injectible ... Read more

December 5, 2018December 5, 2018

For 25th Year, College Scholarship Run by NuFactor Will Honor Hemophilic’s Memory by Helping Others

News

NuFactor Specialty Pharmacy is seeking applicants for next year’s Eric Dostie Memorial College Scholarship, established 25 years ago to honor the memory of an inspirational boy with hemophilia who died ... Read more

November 30, 2018November 30, 2018

Bayer Announces the Approval of Jivi for Hemophilia A in Europe

News

Jivi (BAY94-9027), a lab-made version of the blood clotting factor VIII (FVIII), has been approved by the European Commission for the prophylactic (preventative) treatment of hemophilia A in patients older ... Read more

November 28, 2018November 28, 2018

Gene Therapies Advancing in Trials Offer Hope to Hemophiliacs, But Concerns Abound

News

Gene therapy has the potential to stop hemophilia in its tracks. But such therapy will likely be costly, and can carry risks that have generated some apprehension among patients ... Read more

November 26, 2018November 26, 2018

Potential Gene Therapy for Hemophilia A, AMT-180, May Treat Patients Regardless of Inhibitor Status, uniQure Says

News

A gene therapy from uniQure in early testing, called AMT-180, has the the potential to treat all hemophilia A patients, including those with inhibitors, according to the company. Hemophilia A is caused ... Read more

November 21, 2018November 21, 2018

‘Hemophilia: The Musical’ Lets Teens Confront Their Illness, and Educate Others, via Song

News

The workshop and production process over, it was curtains up for “Hemophilia: The Musical,” a unique theatrical event starring high school students affected by bleeding disorders. Performed at New ... Read more

November 12, 2018November 12, 2018

Patient Enrollment Ongoing in Phase 3 Trial of AMT-061 for Hemophilia B, uniQure Says in Update

News

uniQure is continuing to enroll participants for its global Phase 3 trial (NCT03569891) testing the potential gene therapy AMT-061 in men with severe or moderately severe hemophilia B, according to an ... Read more

November 7, 2018November 7, 2018

Bioverativ to Present New Data on Hemophilia and Other Blood Disorders at ASH

News

Bioverativ will present some of its most recent therapeutic advancements regarding hemophilia and other blood diseases at the 60th Annual Meeting of the American Society of Hematology (ASH) in San Diego, ... Read more

Pin It on Pinterest